Clinical Trial Update: The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer [Phase 4]

View source ↗

Summary

Phase IV trial evaluating the palliative benefit of pamidronate or zoledronic acid in breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pamidronate (pamidronate disodium)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED